Skip to main content

Alzheimer’s disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease

Wang Z, Lewis V, Stehmann C, Verghese S, Senesi M, McGlade A, Ellett L, Doecke JD, Eratne D, Velakoulis D, Masters CL, Collins SJ, Li Q-X.

Stay up to date with the latest news from the AIBL study.

In the spirit of reconciliation, AIBL acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea, and community. We pay our deepest respects to their Elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

Sitemap|Copyright © 2024 AIBL | Website by Ethical Design Co.